However, the mutations in the SBC motif disrupted the ability of BCLAF1-WT to regulate tumor immunity providing BCLAF1 and its SBC motif an attractive target for designing antitumor therapies in HCC. The gene discussed is BCLAF1; the disease is hepatocellular carcinoma.